RNAi 약물전달 시장은 2023-20281년에 1,932억 달러, 예측 기간 중 CAGR은 27.16%로 성장할 것으로 예측됩니다. RNAi 약물전달 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 이 시장은 RNAi 치료제의 높은 표적 친화성과 특이성, 제약·바이오테크놀러지 분야에서 연구 활동의 활발화, 신경질환의 유병률 증가가 촉진하고 있습니다.
| 시장 범위 |
| 기준년 |
2024 |
| 종료년 |
2028 |
| 예측 기간 |
2024-2028 |
| 성장 모멘텀 |
가속 |
| 전년대비 2024년 |
20.94% |
| CAGR |
27.16% |
| 증분액 |
1,932억 달러 |
본 조사에서는 향후 수년간 RNAi 약물전달 시장의 성장을 촉진하는 주요 요인의 하나로 벤더에 의한 RNAi 요법의 연구개발 증가를 들고 있습니다. 또한 복수의 치료 분야에서 RNAi 치료제에 대한 주목의 증가 및 RNAi 어프로치의 과학적 진보도 시장의 큰 수요로 연결될 것으로 생각됩니다.
목차
제1장 개요
제2장 시장 구도
제3장 시장 규모의 평가
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2023
- 시장의 전망 2023-2028
제4장 시장 규모 실적
- 세계의 RNAi 약물전달 시장 2018-2022
- 기술별 부문 분석 2018-2022
- 용도별 부문 분석 2018-2022
- 지역별 부문 분석 2018-2022
- 국가별 부문 분석 2018-2022
제5장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 현황
제6장 시장 세분화 : 기술별
- 시장 세분화
- 비교 : 기술별
- 나노입자에 의한 약물전달 : 시장 규모와 예측 2023-2028
- 폐에 대한 약물전달 : 시장 규모와 예측 2023-2028
- 핵산 약물전달 : 시장 규모와 예측 2023-2028
- 압타머 약물전달 : 시장 규모와 예측 2023-2028
- 시장 기회 : 기술별
제7장 시장 세분화 : 용도별
- 시장 세분화
- 비교 : 용도별
- 감염증 : 시장 규모와 예측 2023-2028
- 종양학 : 시장 규모와 예측 2023-2028
- 심장병학 : 시장 규모와 예측 2023-2028
- 신경학 : 시장 규모와 예측 2023-2028
- 기타 : 시장 규모와 예측 2023-2028
- 시장 기회 : 용도별
제8장 고객 상황
제9장 지역별 상황
- 지역별 세분화
- 비교 : 지역별
- 북미 : 시장 규모와 예측 2023-2028
- 유럽 : 시장 규모와 예측 2023-2028
- 아시아 : 시장 규모와 예측 2023-2028
- 세계의 기타 지역 : 시장 규모와 예측 2023-2028
- 미국 : 시장 규모와 예측 2023-2028
- 영국 : 시장 규모와 예측 2023-2028
- 독일 : 시장 규모와 예측 2023-2028
- 중국 : 시장 규모와 예측 2023-2028
- 캐나다 : 시장 규모와 예측 2023-2028
- 시장 기회 : 지역별
제10장 촉진요인·과제·기회·억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 촉진요인과 과제의 영향
- 시장의 기회·억제요인
제11장 경쟁 구도
제12장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- Alnylam Pharmaceuticals Inc.
- Arbutus Biopharma Corp.
- Arrowhead Pharmaceuticals Inc.
- Bayer AG
- BioNTech SE
- Bristol Myers Squibb Co.
- F. Hoffmann La Roche Ltd.
- Novartis AG
- Novo Nordisk AS
- Phio Pharmaceuticals
- Sanofi SA
- Silence Therapeutics plc
- Sirnaomics Inc.
- Sylentis S.A.
- Thermo Fisher Scientific Inc.
제13장 부록
KSA
The RNAi drug delivery market is forecasted to grow by USD 193.2 bn during 2023-2028, accelerating at a CAGR of 27.16% during the forecast period. The report on the RNAi drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high target affinity and specificity of RNAi therapeutics, increasing research activities in pharmaceutical and biotechnology sectors, and increasing prevalence of neurological disorders.
Technavio's RNAi drug delivery market is segmented as below:
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 20.94% |
| CAGR | 27.16% |
| Incremental Value | $193.2 bn |
By Technology
- Nanoparticle drug delivery
- Pulmonary drug delivery
- Nucleic acid drug delivery
- Aptamer drug delivery
By Application
- Infectious diseases
- Oncology
- Cardiology
- Neurology
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing R and D for RNAi therapy by market vendors as one of the prime reasons driving the RNAi drug delivery market growth during the next few years. Also, increasing focus on RNAi drugs for multiple therapy areas and significant scientific progress in RNAi approach will lead to sizable demand in the market.
The report on the RNAi drug delivery market covers the following areas:
- RNAi drug delivery market sizing
- RNAi drug delivery market forecast
- RNAi drug delivery market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading RNAi drug delivery market vendors that include Alnylam Pharmaceuticals Inc., Arbutus Biopharma Corp., Arrowhead Pharmaceuticals Inc., Bayer AG, Benitec Biopharma Inc., BioNTech SE, Bristol Myers Squibb Co., CureVac AG, e therapeutics PLC, F. Hoffmann La Roche Ltd., Novartis AG, Novo Nordisk AS, Phio Pharmaceuticals, Sanofi SA, Silence Therapeutics PLC, Silenseed Inc., siRNAgen Therapeutics Corp., Sirnaomics Inc., Sylentis S.A., Thermo Fisher Scientific Inc., and TransCode Therapeutics Inc.. Also, the RNAi drug delivery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global RNAi Drug Delivery Market 2018 - 2022
- Historic Market Size - Data Table on Global RNAi Drug Delivery Market 2018 - 2022 ($ billion)
- 4.2 Technology segment analysis 2018 - 2022
- Historic Market Size - Technology Segment 2018 - 2022 ($ billion)
- 4.3 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ billion)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Technology
- 6.1 Market segments
- Chart on Technology - Market share 2023-2028 (%)
- Data Table on Technology - Market share 2023-2028 (%)
- 6.2 Comparison by Technology
- Chart on Comparison by Technology
- Data Table on Comparison by Technology
- 6.3 Nanoparticle drug delivery - Market size and forecast 2023-2028
- Chart on Nanoparticle drug delivery - Market size and forecast 2023-2028 ($ billion)
- Data Table on Nanoparticle drug delivery - Market size and forecast 2023-2028 ($ billion)
- Chart on Nanoparticle drug delivery - Year-over-year growth 2023-2028 (%)
- Data Table on Nanoparticle drug delivery - Year-over-year growth 2023-2028 (%)
- 6.4 Pulmonary drug delivery - Market size and forecast 2023-2028
- Chart on Pulmonary drug delivery - Market size and forecast 2023-2028 ($ billion)
- Data Table on Pulmonary drug delivery - Market size and forecast 2023-2028 ($ billion)
- Chart on Pulmonary drug delivery - Year-over-year growth 2023-2028 (%)
- Data Table on Pulmonary drug delivery - Year-over-year growth 2023-2028 (%)
- 6.5 Nucleic acid drug delivery - Market size and forecast 2023-2028
- Chart on Nucleic acid drug delivery - Market size and forecast 2023-2028 ($ billion)
- Data Table on Nucleic acid drug delivery - Market size and forecast 2023-2028 ($ billion)
- Chart on Nucleic acid drug delivery - Year-over-year growth 2023-2028 (%)
- Data Table on Nucleic acid drug delivery - Year-over-year growth 2023-2028 (%)
- 6.6 Aptamer drug delivery - Market size and forecast 2023-2028
- Chart on Aptamer drug delivery - Market size and forecast 2023-2028 ($ billion)
- Data Table on Aptamer drug delivery - Market size and forecast 2023-2028 ($ billion)
- Chart on Aptamer drug delivery - Year-over-year growth 2023-2028 (%)
- Data Table on Aptamer drug delivery - Year-over-year growth 2023-2028 (%)
- 6.7 Market opportunity by Technology
- Market opportunity by Technology ($ billion)
- Data Table on Market opportunity by Technology ($ billion)
7 Market Segmentation by Application
- 7.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
- 7.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 7.3 Infectious diseases - Market size and forecast 2023-2028
- Chart on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
- Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
- Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
- 7.4 Oncology - Market size and forecast 2023-2028
- Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
- Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
- Chart on Oncology - Year-over-year growth 2023-2028 (%)
- Data Table on Oncology - Year-over-year growth 2023-2028 (%)
- 7.5 Cardiology - Market size and forecast 2023-2028
- Chart on Cardiology - Market size and forecast 2023-2028 ($ billion)
- Data Table on Cardiology - Market size and forecast 2023-2028 ($ billion)
- Chart on Cardiology - Year-over-year growth 2023-2028 (%)
- Data Table on Cardiology - Year-over-year growth 2023-2028 (%)
- 7.6 Neurology - Market size and forecast 2023-2028
- Chart on Neurology - Market size and forecast 2023-2028 ($ billion)
- Data Table on Neurology - Market size and forecast 2023-2028 ($ billion)
- Chart on Neurology - Year-over-year growth 2023-2028 (%)
- Data Table on Neurology - Year-over-year growth 2023-2028 (%)
- 7.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 7.8 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ billion)
- Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.10 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ billion)
- Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.11 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 Alnylam Pharmaceuticals Inc.
- Alnylam Pharmaceuticals Inc. - Overview
- Alnylam Pharmaceuticals Inc. - Product / Service
- Alnylam Pharmaceuticals Inc. - Key news
- Alnylam Pharmaceuticals Inc. - Key offerings
- 12.4 Arbutus Biopharma Corp.
- Arbutus Biopharma Corp. - Overview
- Arbutus Biopharma Corp. - Product / Service
- Arbutus Biopharma Corp. - Key offerings
- 12.5 Arrowhead Pharmaceuticals Inc.
- Arrowhead Pharmaceuticals Inc. - Overview
- Arrowhead Pharmaceuticals Inc. - Business segments
- Arrowhead Pharmaceuticals Inc. - Key offerings
- Arrowhead Pharmaceuticals Inc. - Segment focus
- 12.6 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- 12.7 BioNTech SE
- BioNTech SE - Overview
- BioNTech SE - Product / Service
- BioNTech SE - Key offerings
- 12.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- 12.9 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- 12.10 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 12.11 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key news
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- 12.12 Phio Pharmaceuticals
- Phio Pharmaceuticals - Overview
- Phio Pharmaceuticals - Product / Service
- Phio Pharmaceuticals - Key offerings
- 12.13 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- 12.14 Silence Therapeutics plc
- Silence Therapeutics plc - Overview
- Silence Therapeutics plc - Product / Service
- Silence Therapeutics plc - Key offerings
- 12.15 Sirnaomics Inc.
- Sirnaomics Inc. - Overview
- Sirnaomics Inc. - Product / Service
- Sirnaomics Inc. - Key offerings
- 12.16 Sylentis S.A.
- Sylentis S.A. - Overview
- Sylentis S.A. - Product / Service
- Sylentis S.A. - Key offerings
- 12.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- 13.5 Data procurement
- 13.6 Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
